Cite
HARVARD Citation
Narula, N. et al. (n.d.). P437 Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn's disease patients who have failed infliximab. Journal of Crohn's and colitis. pp. S325-S326. [Online].